NCT03004950View on ClinicalTrials.gov

Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)

CompletedOBSERVATIONAL
Enrollment

922

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

February 28, 2022

Study Completion Date

June 30, 2023

Conditions
Acute Renal FailureKidney DiseasesChronic Kidney DiseaseCoronary (Artery); Disease
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

US Department of Veterans Affairs

FED

lead

University of Pittsburgh

OTHER

NCT03004950 - Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON) | Biotech Hunter | Biotech Hunter